Newsroom

BOSTON e MILANO--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) oggi ha annunciato l'introduzione di polizze assicurative primarie contro gli infortuni a livello nazionale e multinazionale in Italia. "Siamo lieti di lanciare la nostra soluzione primaria modulare e proprietaria contro gli infortuni, espressamente progettata per soddisfare l'esigenza di semplicità, chiarezza e trasparenza nella gestione del rischio di infortunio dei nostri clienti”, ha dichiarato Francesco Longoba...

WASHINGTON--(BUSINESS WIRE)--The Susan G. Komen® Center for Public Policy announced its 2026 state and federal advocacy priorities, underscoring the urgent need to protect the breast cancer community from impending changes that will drastically change affordability and access to health care. At both the federal and state levels, policymakers are weighing proposals that could significantly increase costs, reduce coverage and weaken critical cancer programs. From the uncertain future of access to...

ATLANTA--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield announced today a new, multi-year provider network agreement with United Digestive, a physician practice management company supporting gastrointestinal providers and partner practices throughout the Southeast. United Digestive has partner practices in Georgia, Florida, North Carolina, and South Carolina, many of whom have served their communities for more than 40 years. “We are pleased to continue our valued partnership with United Dig...

BROOKLINE, Mass.--(BUSINESS WIRE)--Facility Grid, leading provider of cloud-based software streamlining Cx and OR in the construction industry, announces Daniel Russo as its new CEO....

LEHI, Utah--(BUSINESS WIRE)--NetDocuments, the cloud-native, AI-enabled legal document management platform, today announced the completion of its acquisition of eDOCS from OpenText. The deal includes the full product portfolio and the dedicated eDOCS team, expanding NetDocuments’ global presence to over 90 countries and providing the eDOCS community with a long-term home at a company fully focused on legal professionals. This acquisition enhances NetDocuments’ global ability to deliver leading...

CHAILLÉ-SOUS-LES-ORMEAUX, Frankrijk--(BUSINESS WIRE)--Hoffmann Green Cement Technologies (ISIN: FR0013451044, ticker: ALHGR) (“Hoffmann Green Cement” of het “Bedrijf”), een industriële speler die zich inzet voor het koolstofvrij maken van de bouwsector en innovatieve, koud geproduceerde, klinkervrije cement ontwikkelt en op de markt brengt, maakt bekend dat het bedrijf een ATec (Franse technische goedkeuring, de Avis Technique) heeft verkregen ter validering van het gebruik van beton op basis v...

CHAILLÉ-SOUS-LES-ORMEAUX, France--(BUSINESS WIRE)--Hoffmann Green Cement Technologies (ISIN : FR0013451044, symbole : ALHGR) (« Hoffmann Green Cement » ou la « société »), acteur industriel engagé dans la décarbonation du secteur de la construction qui conçoit et commercialise des ciments innovants produits à froid et sans clinker, annonce avoir obtenu une évaluation technique (ATec) validant l’utilisation du béton formulé avec son ciment H-UKR 0 % clinker pour les applications de superstructur...

DUBLIN--(BUSINESS WIRE)--The "Small Calibre Military Ammunition - Market and Technology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The study provides a model of the market size, in-depth insights procurement opportunities, mapping out the scope, scale, and timelines of opportunities worldwide. It also offers a solid understanding of the current situation in the small calibre military ammunition business landscape and what should be expected for the future. The...

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE:IEX) will release its fourth quarter 2026 results February 4, 2026, prior to market open....

カリフォルニア州サンカルロス--(BUSINESS WIRE)--（ビジネスワイヤ） -- グローバルなオンコロジー企業であるBeOne Medicines Ltd.（Nasdaq：ONC、HKEX：06160、SSE：688235）は、HER2陽性（HER2+）の局所進行または転移性胃食道腺がん（GEA）に対する一次治療として、HER2標的二重特異性抗体である「ZIIHERA®（ザニダタマブ）」を化学療法と併用し、さらにPD-1阻害薬である「TEVIMBRA®（チスレリズマブ）」の有無を比較評価した第3相HERIZON-GEA-01試験の全結果を発表しました。これらのデータは、初回の全生存期間（OS）中間解析を含め、2026年1月8日午前8:57〜9:07（太平洋標準時）に開催される米国臨床腫瘍学会消化器がんシンポジウム（ASCO GI）において、レイト・ブレイキング・アブストラクトの口頭発表（#LBA285）として発表されます。 HERIZON-GEA-01試験は、二重主要評価項目の1つである無増悪生存期間（PFS）を達成し、対照群と比較して、両試験群において統計学的に有意かつ臨...